spiperone has been researched along with ncq 298 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Billings, J; Chumpradit, S; Kung, HF; Kung, MP; Mach, R | 1 |
| Boundy, VA; Elder, ST; Evora, PH; Hoffman, PL; Jackson, JR; Luedtke, RR; Mach, RH; Nowak, PA; Scripko, JG; Unsworth, CD | 1 |
| Jerning, E; Malmberg, A; Mohell, N | 1 |
3 other study(ies) available for spiperone and ncq 298
| Article | Year |
|---|---|
Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT.
Topics: Animals; Benzamides; Dopamine Agents; Dopamine D2 Receptor Antagonists; Fluorine Radioisotopes; Iodine Radioisotopes; Macaca fascicularis; Male; Pyrrolidines; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1993 |
18F-labeled benzamides for studying the dopamine D2 receptor with positron emission tomography.
Topics: Animals; Baculoviridae; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Fluorine Radioisotopes; Molecular Structure; Moths; Piperidines; Pituitary Neoplasms; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Serotonin; Recombinant Proteins; Structure-Activity Relationship; Tomography, Emission-Computed; Tumor Cells, Cultured | 1993 |
Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites.
Topics: Animals; Benzamides; Cell Line; Corpus Striatum; Dopamine Antagonists; Humans; Mice; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Salicylamides; Spiperone | 1996 |